Inventor · disambiguated record
Patrick Mehlen
Also filed as: MEHLEN PATRICK · MEHLEN PATRICK ETIENNE ROGER
4 granted patents·12 pending applications·0 citations·filing 2007–2024
55Inventor score
Top patents by PatentIndex Score
16 records- 0159US2025002572A1Combined treatment with netrin-1 interfering drug and immune checkpoint inhibitors drugsNETRIS PHARMA·Filed 2024·Application pending·0 cites
- 0253US11203641B2Screening for anti-cancer compounds using netrin-1 activityCENTRE NAT RECH SCIENT·Filed 2018·Granted Dec 21, 2021·0 cites·13 claims
- 0351US2025215071A1Novel Mcl-1 inhibitor and combination of Mcl-1 and a BH3 mimetic, such as a Bcl-2 inhibitorNETRIS PHARMA·Filed 2023·Application pending·0 cites
- 0449US2023303676A1Anti-netrin-1 antibody to treat liver inflammationNETRIS PHARMA·Filed 2023·Application pending·0 cites
- 0548US2015004159A1Screening for anti-cancer compounds using netrin-1 activityCENTRE NAT RECH SCIENT·Filed 2014·Application pending·0 cites
- 0648US2011229485A1Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastomaCT NAT DE LA RECH SCIENTFIQUE CNRS·Filed 2009·Application pending·0 cites
- 0746US2024342322A1Netrin-1 detection, companion test and therapy based on radiationsNETRIS PHARMA·Filed 2022·Application pending·0 cites
- 0845US12162932B2Combined treatment with Netrin-1 interfering drug and immune checkpoint inhibitors drugsNETRIS PHARMA·Filed 2018·Granted Dec 10, 2024·0 cites·10 claims
- 0943US8329653B2Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disordersMEHLEN PATRICK·Filed 2007·Granted Dec 11, 2012·0 cites·17 claims
- 1043US2014186364A1Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastomaCENTRE NAT RECH SCIENT·Filed 2013·Application pending·0 cites
- 1140US2009226458A1Screening For Anti-Cancer Compounds Using Netrin-1 ActivityCT LEON BERARD·Filed 2007·Application pending·0 cites
- 1233US9895439B2Combined treatment with netrin-1 interfering drug and chemotherapeutic drugNETRIS PHARMA·Filed 2013·Granted Feb 20, 2018·0 cites·4 claims
- 1331US2013336972A1Recombinant fc-fusion protein of the fifth fibronectin type iii domain of dccKLEIN CHRISTIAN·Filed 2011·Application pending·0 cites
- 1423US2016369242A1Method for producing induced pluripotent cellsCENTRE LEON BERARD·Filed 2015·Application pending·0 cites
- 1521US2013089548A1Method and compositions to induce apoptosis of tumoral cells expressing shhMEHLEN PATRICK·Filed 2011·Application pending·0 cites
- 1617US2012015364A1Method for the selection of endothelial cells death inducers via netrin-1 and its applicationsMEHLEN PATRICK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Mehlen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →